After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets

After the Rally: Pfizer's COVID Booster vs. O...

Up next

CNBC Investing Club: Cramer’s Morning Take on Alphabet 3/13/26

Cramer says this is an ‘exquisite’ moment to buy stocks. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charitable Trust – and see up cl ...  Show more

SOTS 2nd Hour: PCE Breakdown, D.C.-Iran latest, & ServiceNow CEO's AI Warning 3/13/26

A busy 24 hours between DC headlines and PCE data... Carl Quintanilla, Sara Eisen, and Michael Santoli kicked off the hour with the latest on both fronts, before discussing the implications for markets, traders, and the Federal Reserve. Plus: hear ServiceNow CEO Bill McDermott's ...  Show more

Recommended Episodes

Magnificent Seven Stocks: What’s Going on With Apple, Tesla, and Alphabet?
Investing Insights

Sarah Hansen, Morningstar Inc markets reporter, explains why Apple and Tesla are diverging from the rest of the Magnificent Seven stocks. Also, details into a first ever dividend from Alphabet. Preston Caldwell, senior US economist for Morningstar Research Services, discusses ...

  Show more

Musk’s Cheaper EVs Calm Fears Over Tesla Strategy
Bloomberg Businessweek

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Technology Co-Host Ed Ludlow discusses Tesla easing concerns about disappointing earnings results and diminished growth by vowing to launch less-expensive vehicles as soon as late this year. Bloomberg ...  Show more

Apple Intelligence
Wall Street Breakfast

Apple (AAPL) unveils new Apple Intelligence, iOS, tvOS at WWDC. (00:24) CVS generics recalled two times more than Walgreens (WBA) generics: report. (02:09) DXC Technology jumps on report of joint bid from Apollo (APO), Kyndryl (KD). (03:16) Episode transcripts seekingalpha.com/ws ...  Show more

Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
Real Vision: Finance & Investing

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more